News About: Pharm. Industry


50 billion Won sales targeted in 1999 by GlaxoWellcome Korea.

GlaxoWellcome Korea (President: Kim Jin-ho) established the company management objective this year aiming at a base construction of business profit ensuing the previous year by intensifying the sales organization and ...

1998 Sales growth of leading drug makers slow.

The sales of leading pharmaceutical manufacturers last year went up slow at merely 4% level of its growth over the previous year, YK Newletter survey reported, which was attributed largely to the nationwide ec...

Discount after sales transaction to cut or eliminate.

So far the drug company has traditionally provided so-called "Discount after sales" to the customer, a sort of allowance payable at the end of year or some time after the sales transaction. Since such allowance has be...

Insurance reimbursement policy of imported drugs painful to foreign pharmaceutical firms.

The government approved the insurance reimbursement for imported drugs to be implemented from July 1 at far lower prices than the level in current practice, and therefore foreign pharmaceutical firms raised its proble...

Survey on top executives over pharmaceutical economy (1)

Survey on top executives over pharmaceutical economy (1) Pharmaceutical business recovery to predict from year after next. YK Consultant surveyed "The pharmaceutical economic perspective this year and countermeasu...

Survey on top executives over pharmaceutical economy (1)

Survey on top executives over pharmaceutical economy (1) Pharmaceutical business recovery to predict from year after next. YK Consultant surveyed "The pharmaceutical economic perspective this year and countermeasu...

Survey on top executives over pharmaceutical economy (2)

With regard to the changes in drug distribution channel even after the implementation of the medical/pharmacy separation system, 62.9% of respondents indicated to intensify more the wholesale transaction, 11.4% to rei...

Strategic tie-up between domestic and foreign pharmaceutical corporations.

From the second half of 1990s many local foreign pharmaceutical corporations and domestic companies were trying to make a business cooperation in an attempt to maximize their sales turnover within the mutual complemen...

New products launched by foreign multinational corporations estimated to 2 to 3 billion dollars?

A rumour is spreaded in the drug industry that about 2 to 3 billion dollar worth of new products would be soon launched this year in the Korean market by foreign multinational pharmaceutical corporations. However,...

Full efforts focused on OTC best sellers.

Drug industry encountered many difficult situations caused by the insurance drug price down and depressed hospital markets thereby and therefore tried to maximize their sales productivity. In an attempt to alleviate u...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.